Eric Allen Rose - 18 Mar 2026 Form 3 Insider Report for MESOBLAST LTD (MESO)

Reporting relationship
Chief Medical Officer,Director, Director
Issuer ticker
MESO
Reported as of
18 Mar 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
18 Mar 2026, 09:34:32 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Eric Allen Rose

Key filing fact

Eric Allen Rose filed Form 3 for MESOBLAST LTD (MESO) on 18 Mar 2026.

Key facts

  • This page summarizes Eric Allen Rose's Form 3 filing for MESOBLAST LTD (MESO).
  • 0 reported transactions and 16 derivative rows are listed below.
  • Accepted by SEC: 18 Mar 2026, 09:34.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002120513 Primary reporting owner

ROSE ERIC ALLEN

Relationship
Chief Medical Officer,Director, Director
Address
LEVEL 38, 55 COLLINS STREET, MELBOURNE, VICTORIA, AUSTRALIA
Signature
/s/ Eric Allen Rose
Signature date
18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MESO holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,034,554
Date
18 Mar 2026
Ownership
Direct
MESO holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
714,720
Date
18 Mar 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MESO holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
33,333
Exercise price
$1.81
MESO holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
33,333
Exercise price
$1.81
MESO holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
33,334
Exercise price
$1.81
MESO holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
716,667
Exercise price
$1.01
MESO holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
406,922
Exercise price
$0.3600
MESO holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
406,922
Exercise price
$0.3600
MESO holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
406,921
Exercise price
$0.3600
MESO holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
148,000
Exercise price
$0.3500
MESO holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
716,667
Exercise price
$1.01
MESO holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
145,562
Exercise price
$0.9700
MESO holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
145,562
Exercise price
$0.9700
MESO holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
460,896
Exercise price
$0.9700
MESO holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
716,666
Exercise price
$1.01
MESO holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
592,000
Exercise price
$0.3500
Footnotes
F2
MESO holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
630,666
Exercise price
$0.9700
Footnotes
F3
MESO holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
820,000
Exercise price
$2.46
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Such Ordinary Shares are represented by American Depositary Shares.

Footnote F2

Granted on October 16, 2023. Vesting is dependent on Mr. Rose achieving certain milestones.

Footnote F3

Granted on August 27, 2024. Vesting is dependent on Mr. Rose achieving certain milestones.

Footnote F4

Granted on August 26, 2025. Vesting is dependent on Mr. Rose achieving certain milestones.

SEC remarks

1. All exercise prices are in Australian dollars.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .